Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,459 | 728 | 99.9% |
| Education | $16.90 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,576 | 106 | $0 (2024) |
| ABBVIE INC. | $1,178 | 87 | $0 (2024) |
| Amgen Inc. | $1,045 | 69 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $923.45 | 51 | $0 (2024) |
| Novo Nordisk Inc | $901.93 | 54 | $0 (2024) |
| GlaxoSmithKline, LLC. | $887.17 | 68 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $674.40 | 40 | $0 (2024) |
| Lilly USA, LLC | $531.05 | 32 | $0 (2024) |
| PFIZER INC. | $492.49 | 30 | $0 (2024) |
| Merck Sharp & Dohme LLC | $459.73 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,627 | 84 | Novo Nordisk Inc ($220.49) |
| 2023 | $1,934 | 115 | ABBVIE INC. ($332.03) |
| 2022 | $1,516 | 86 | AstraZeneca Pharmaceuticals LP ($411.33) |
| 2021 | $1,472 | 91 | AstraZeneca Pharmaceuticals LP ($337.80) |
| 2020 | $1,027 | 67 | AstraZeneca Pharmaceuticals LP ($211.59) |
| 2019 | $1,467 | 86 | AstraZeneca Pharmaceuticals LP ($227.91) |
| 2018 | $1,468 | 83 | AstraZeneca Pharmaceuticals LP ($516.87) |
| 2017 | $1,964 | 118 | AstraZeneca Pharmaceuticals LP ($404.09) |
All Payment Transactions
730 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: VACCINES | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: PAIN | ||||||
| 11/11/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Hematology | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Genetically Defined Disease | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: Obesity | ||||||
| 10/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Inflammation | ||||||
| 10/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.16 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Bone Health | ||||||
| 09/30/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $43.34 | General |
| Category: Hematology | ||||||
| 09/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: PAIN | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Inflammation | ||||||
| 09/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 47 | 5,379 | 7,947 | $694,380 | $271,981 |
| 2022 | 42 | 5,180 | 7,344 | $621,119 | $241,880 |
| 2021 | 47 | 5,831 | 8,662 | $694,697 | $271,348 |
| 2020 | 47 | 5,700 | 8,476 | $692,693 | $245,396 |
All Medicare Procedures & Services
183 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 409 | 906 | $227,406 | $76,190 | 33.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 333 | 333 | $66,600 | $43,017 | 64.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 322 | 322 | $38,640 | $26,282 | 68.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 173 | 236 | $39,884 | $14,234 | 35.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 170 | 170 | $29,750 | $12,221 | 41.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 39 | 39 | $26,130 | $11,013 | 42.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 391 | 728 | $34,944 | $9,517 | 27.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 396 | 879 | $13,097 | $7,359 | 56.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 42 | 54 | $18,252 | $7,243 | 39.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 31 | 33 | $18,711 | $7,108 | 38.0% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 27 | 95 | $12,160 | $5,236 | 43.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 170 | 170 | $6,800 | $5,126 | 75.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 265 | 507 | $17,745 | $4,827 | 27.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 349 | 397 | $15,086 | $4,100 | 27.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 116 | 234 | $14,040 | $3,809 | 27.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 82 | 129 | $13,674 | $3,742 | 27.4% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 29 | 35 | $8,890 | $3,409 | 38.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 282 | 377 | $11,310 | $3,111 | 27.5% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 346 | 403 | $9,269 | $2,549 | 27.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $3,850 | $2,316 | 60.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 25 | 45 | $4,725 | $2,239 | 47.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 86 | 103 | $6,901 | $1,856 | 26.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 60 | 100 | $5,400 | $1,438 | 26.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 44 | 44 | $1,760 | $1,327 | 75.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 32 | $2,848 | $1,206 | 42.4% |
About Dr. Jeffrey Harris, D.O
Dr. Jeffrey Harris, D.O is a Family Medicine healthcare provider based in Newport News, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2013. The National Provider Identifier (NPI) number assigned to this provider is 1023457991.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Harris, D.O has received a total of $12,476 in payments from pharmaceutical and medical device companies, with $1,627 received in 2024. These payments were reported across 730 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($12,459).
As a Medicare-enrolled provider, Harris has provided services to 22,090 Medicare beneficiaries, totaling 32,429 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 183 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Newport News, VA
- Active Since 06/24/2013
- Last Updated 06/24/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1023457991
Products in Payments
- FARXIGA (Drug) $1,606
- JARDIANCE (Drug) $650.66
- XARELTO (Drug) $622.78
- UBRELVY (Drug) $451.47
- TRELEGY ELLIPTA (Drug) $420.82
- Ozempic (Drug) $416.57
- NURTEC ODT (Drug) $392.81
- VRAYLAR (Drug) $343.64
- BREZTRI (Drug) $311.35
- Aimovig (Biological) $305.40
- EVENITY (Biological) $275.20
- JANUVIA (Drug) $273.01
- Otezla (Drug) $254.87
- BEVESPI AEROSPHERE (Drug) $228.99
- ENTRESTO (Drug) $222.99
- ELIQUIS (Drug) $214.35
- SHINGRIX (Biological) $197.20
- TRULICITY (Drug) $190.41
- TRINTELLIX (Drug) $187.77
- Trintellix (Drug) $180.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Newport News
Dr. Chester Fisher, Md, MD
Family Medicine — Payments: $113,186
Charles Ginsburgh, Md, MD
Family Medicine — Payments: $92,538
Thomas Robeson, Md, MD
Family Medicine — Payments: $61,182
Meenal Dwyer, M.d, M.D
Family Medicine — Payments: $11,792
Charles Phillips, Md, MD
Family Medicine — Payments: $11,644
Darany Toy, D.o, D.O
Family Medicine — Payments: $9,428